172 related articles for article (PubMed ID: 28497194)
1. Treatment and outcomes of recurrent hepatocellular carcinomas.
Joliat GR; Allemann P; Labgaa I; Demartines N; Halkic N
Langenbecks Arch Surg; 2017 Aug; 402(5):737-744. PubMed ID: 28497194
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection.
Meniconi RL; Komatsu S; Perdigao F; Boëlle PY; Soubrane O; Scatton O
Surgery; 2015 Mar; 157(3):454-62. PubMed ID: 25633732
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas.
Joliat GR; Labgaa I; Uldry E; Demartines N; Halkic N
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):792-796. PubMed ID: 29538038
[TBL] [Abstract][Full Text] [Related]
5. Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular Carcinoma.
Shindoh J; Kawamura Y; Kobayashi Y; Akuta N; Kobayashi M; Suzuki Y; Ikeda K; Hashimoto M
J Gastrointest Surg; 2020 Jan; 24(1):50-57. PubMed ID: 31190124
[TBL] [Abstract][Full Text] [Related]
6. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
[TBL] [Abstract][Full Text] [Related]
7. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score Model.
Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Chiou YY; Lin HC; Huo TI
Ann Surg; 2016 Mar; 263(3):538-45. PubMed ID: 25775062
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
9. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
10. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study.
Wang K; Liu G; Li J; Yan Z; Xia Y; Wan X; Ji Y; Lau WY; Wu M; Shen F
Eur J Surg Oncol; 2015 Feb; 41(2):236-42. PubMed ID: 25434327
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
[TBL] [Abstract][Full Text] [Related]
12. Salvage hepatectomy for local recurrence of hepatocellular carcinomas offers survival comparable to that of matched patients who undergo primary hepatectomies.
Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
Eur J Surg Oncol; 2017 Jun; 43(6):1076-1082. PubMed ID: 28456443
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma.
Kutlu OC; Chan JA; Aloia TA; Chun YS; Kaseb AO; Passot G; Yamashita S; Vauthey JN; Conrad C
Cancer; 2017 May; 123(10):1817-1827. PubMed ID: 28085184
[TBL] [Abstract][Full Text] [Related]
14. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis.
Tabrizian P; Jibara G; Shrager B; Schwartz M; Roayaie S
Ann Surg; 2015 May; 261(5):947-55. PubMed ID: 25010665
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
Kim HR; Cheon SH; Rha SY; Lee S; Han KH; Chon CY; Lee JD; Sung JS; Chung HC
Asia Pac J Clin Oncol; 2011 Sep; 7(3):258-69. PubMed ID: 21884437
[TBL] [Abstract][Full Text] [Related]
19. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinoma.
Nishikawa H; Osaki Y; Iguchi E; Takeda H; Ohara Y; Sakamoto A; Hatamaru K; Saito S; Nasu A; Kita R; Kimura T
Anticancer Res; 2012 Nov; 32(11):5059-65. PubMed ID: 23155279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
